Citigroup’s EnteroMedics Inc. ETRM Stock Holding History

Citigroup’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Hold	0	–	–	–	7989
2016 Q1	–	Hold	0	–	–	–	8288
2015 Q4	–	Sell	-1	Closed	–	–	8369
2015 Q3	$0	Buy	+1	New	+$319	﹤0.01%	8373
2015 Q2	–	Sell	-5	Closed	-$5K	–	8184
2015 Q1	$5K	Buy	+5	New	+$6.03K	﹤0.01%	6751
2014 Q4	–	Sell	-1	Closed	-$1K	–	7717
2014 Q3	$1K	Buy	+1	New	+$1.47K	﹤0.01%	7029
2014 Q2	–	Hold	0	–	–	–	7709
2014 Q1	–	Sell	-1	Closed	-$1K	–	7559
2013 Q4	$1K	Sell	1 -3	-75%	-$4.83K	﹤0.01%	6950
2013 Q3	$5K	Buy	+4	New	+$4.66K	﹤0.01%	6446
2013 Q2	–	Hold	0	–	–	–	6917

Other funds holding ETRM

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Citigroup's ETRM Position: Q2 2016 in Review

Citigroup held its EnteroMedics Inc. (ETRM) position steady in Q2 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7989.

Citigroup first reported a position in ETRM in Q3 2013 and has held it in 5 quarters since. The position peaked at $5K in Q1 2015. 24 funds tracked by Wall St. Rank hold ETRM as of Q2 2016.

Citigroup held 0 shares of EnteroMedics Inc. worth $0 as of Q2 2016.
Citigroup left its EnteroMedics Inc. share count unchanged in Q2 2016.
EnteroMedics Inc. made up ﹤0.01% of Citigroup's portfolio in Q2 2016, its #7989 holding.
Citigroup first reported a position in EnteroMedics Inc. in Q3 2013 and has held it in 5 quarters since.
Citigroup's EnteroMedics Inc. position peaked at $5K in Q1 2015.
24 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.